Pai Holdings LLC: FDA regulatory profile

Pai Holdings LLC appears in 4 indexed U.S. FDA records: 4 recall records, naming 4 distinct products. Latest dated event: a recall record dated 2026-06-24. Observations run 2026-06-24 to 2026-06-24, 4 dated records across 1 calendar year, busiest 2026 with 4. Recalls: 4 Class II (100%); 4 ongoing by lifecycle status, reported 2026-06-24; 4 with an FDA recall number, 4 with an initiation date, across 1 state, grouped into 1 FDA recall event. Every figure here is a count or a date computed from the indexed FDA datasets over a finite window: coverage-limited activity signals, never quality ratings or judgements about the firm. Recall records: VistaPharm (D-0589-2026, Class II, 2026-06-24), VistaPharm (D-0590-2026, Class II, 2026-06-24), VistaPharm (D-0591-2026, Class II, 2026-06-24) and VistaPharm (D-0592-2026, Class II, 2026-06-24). Recalling-firm addresses are recorded in SC. Its recall lines are grouped by the FDA into 1 event identifier: 99000. Distribution is recorded in the source as U.S.A. Nationwide. Recalling-firm country of record: United States.

Regulatory snapshot

Indexed records 4
Recall records 4
Shortage entries 0
Source rows filed 0
Approval records 0
Current shortages 0
Resolved shortages 0
Discontinued shortages 0
Unique products 4
Recall classifications Class II: 4
Recall statuses Ongoing: 4
First observed 2026-06-24
Latest observed 2026-06-24
Latest event type recall
Dated observations 4
Years covered 1
Span (days) 0
Busiest year 2026 (4 records)
Recall states 1
With recall number 4 of 4
FDA recall events 1
Related firms / shortages 0 / 0

Counts, not a rating. Coverage-limited activity signals over the ingested window — never reputational scores or judgements about the firm or its products.

Record breakdown

DimensionValueRecordsShare
Recall classificationClass II4100%
Recall statusOngoing4100%

Recall history (4)

Every enforcement report attributed to this firm, newest first. Classification is the FDA's severity tier, status its lifecycle position — neither is a safety statement.

Product (as published)Recall numberClassificationStatusReportedInitiated
VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 25 Grams Activated Char D-0589-2026 Class II Ongoing 2026-06-24 2026-05-15
VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 50 Grams Activated Char D-0590-2026 Class II Ongoing 2026-06-24 2026-05-15
VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 25 Grams Activated Cha D-0591-2026 Class II Ongoing 2026-06-24 2026-05-15
VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 50 Grams Activated Cha D-0592-2026 Class II Ongoing 2026-06-24 2026-05-15

Browse the wider classification index: Class II recalls.

Products and drugs named (4)

De-duplicated by record entity, not raw source row.

Source limitations

Built from the 4 ingested FDA records for this firm (4 recall, 0 shortage, 0 approval) — not its full regulatory history. The window is finite and can lag the live record, and alternate spellings of a firm name may sit under separate profiles. Confirm details at the linked official source. Regulatory information only: no safety assessment, no recommendation.

Where to go next

Source & provenance

Official source
https://open.fda.gov/apis/drug/enforcement/
Source dataset
openFDA (enforcement + shortages + Drugs@FDA)
Publication date
Not available
Ingested
2026-08-22

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.